How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

    The content on this page is not current guidance and is only for the purposes of the consultation process.

    4 Further evidence

    Evidence generation

    4.1 Further evidence will be generated while the 3 recommended technologies are used in the NHS to address the immediate unmet need, with appropriate safety processes in place. The clinical experts stressed the importance of managing clinical risk. The companies advised that they have risk management systems in place but that risk should be managed according to local care protocols. All the technologies are supported by trained practitioners in NHS Talking Therapies Services that check in with users on a weekly or fortnightly basis by telephone calls or messaging. These digitally enabled therapies are a way to increase access to treatment with support from a healthcare professional. The committee concluded that Space from Depression, Deprexis and Beating the Blues can be used as options for adults with depression if used with appropriate risk management processes in place while evidence is generated. The main outcomes prioritised by the committee for evidence generation are outlined in section 1.2.

    Research only recommendations

    4.2 There was not enough evidence to recommend Minddistrict, Iona Mind and Wysa for early access in the NHS. They should be used only in research. Research should be within the scope of this assessment and include well-designed and adequately powered studies with appropriate comparators in NHS Talking Therapies services. Studies should address the evidence gaps outlined in this guidance and demonstrate the benefit of using these technologies for adults with depression.